|
V4573
|
(4E)-SUN9221 |
222318-55-0 |
(4E)-SUN9221 is a potent α1-adrenergic receptor and 5-HT2 receptor blocker (antagonist) with anti-hypertensive (blood pressure lowering) and antiplatelet aggregation effects. |
|
V4720
|
(±)-BI-D |
1416258-16-6 |
(±)-BI-D is a novel and potent allosteric/noncatalytic site integrase inhibitor that binds integrase at the LEDGF/p75 binding site. |
|
V4605
|
5Z-7-Oxozeaenol |
253863-19-3 |
5Z-7-Oxozeaenol, a natural anti-protozoan compound isolated from fungae, is a novel, potent irreversible / covalent and selective inhibitor ofTAK1andVEGF-R2withIC50s of 8 nM and 52 nM, respectively. |
|
V4657
|
A-437203 |
220519-06-2 |
A-437203 is a novel, potent and selectiveD3receptor antagonist withKiof 71, 1.6, and 6220 nM for D2, D3, and D4receptors, respectively. |
|
V4566
|
ABBV-4083 |
1809266-03-2 |
ABBV-4083, a Tylosin A analog withimprovements in anti-Wolbachiaand anti-filarial activity and oral pharmacokinetic properties, is a novel macrofilaricidal agent which acts by targeting the worm-symbiont Wolbachia bacterium. |
|
V4690
|
ACY-1083 |
1708113-43-2 |
ACY-1083 is a novel, potent, selective and brain-penetrant HDAC6 inhibitor with an IC50 of 3 nM. |
|
V4689
|
ACY-957 |
1609389-52-7 |
ACY-957 is a novel, potent and selective inhibitor ofHDAC1andHDAC2isoforms withIC50s of 7 nM, 18 nM, and 1300 nM against HDAC1/2/3, respectively. |
|
V4985
|
Ajulemic acid |
137945-48-3 |
Ajulemic acid (also known as lenabasum) is a cannabinoid CB2 receptor agonist with the potential for treatment of skin-predominant dermatomyositis. |
|
V4738
|
AMG2850 |
1470018-52-0 |
AMG2850 is a novel, potent, orally bioavailable and selectivesmall molecule antagonist oftransient receptor potential melastatin 8 (TRPM8). |
|
V5074
|
Amrubicin HCl (Calsed) |
92395-36-3 |
Amrubicin HCl (also known as SM-5887 hydrochloride), a third-generation synthetic 9-amino-anthracycline, is a potent DNAtopoisomerase IIinhibitor with antineoplastic activity. |
|
V4846
|
AMY-101 acetate |
1427001-89-5 |
AMY-101 (also known as Cp40) is a peptidic inhibitor of the central complement component C3. |
|
V5051
|
ANT431 |
1639972-90-9 |
ANT431 is a novel and potent inhibitor of metallo-β-lactamase with the potential for the treatment of carbapenem-resistant enterobacteriaceae infections. |
|
V5028
|
Arfolitixorin |
31690-11-6 |
Arfolitixorin, an intravenously administered folate-based compound,is a novel and potent antifolate modulator that isbeing developed by Isofol Medical AB, for the treatment of cancer. |
|
V4565
|
ARN 077 |
1373625-34-3 |
ARN 077 (ARN-077) is a novel, potent and selectiveN-acylethanolamine acid amidase (NAAA)inhibitor with anIC50of 7 nM for human NAAA. |
|
V4903
|
Arzoxifene HCl |
182133-27-3 |
Arzoxifene (also known as LY353381) is a novel, potent, synthetic aromatic derivative, and selectiveestrogen receptorantagonist in mammary and uterine tissue while acting as an estrogen agonist to maintain bone density and lower serum cholesterol. |
|
V5005
|
Atrial Natriuretic Peptide (ANP) (1-28) |
89213-87-6 |
Carperitide [SUN4936; SUN-4936;Atrial Natriuretic Peptide (ANP) (1-28), novel human, porcine] is an endogenous 28-amino acid hormone produced/ecreted by the human heart in response to cardiac injury and mechanical stretch. |
|
V4991
|
AZD3147 |
1101810-02-9 |
AZD3147 (AZD-3147) is an highly potent and selective dual inhibitor of mTORC1/2 with IC50 of 1.5 nM. |
|
V4982
|
AZD3458 (PI3Kγ inhibitor 3) |
2132961-46-5 |
AZD-3458 (PI3Kγ inhibitor 3) is a novel, potent, orally bioavailable and highly isoform selectivePI3Kγinhibitor with anticancer activity. |
|
V4732
|
Balamapimod |
863029-99-6 |
Balamapimod (formerly also known as MKI-833) is a novel, potent, and reversible Ras/Raf/MEK inhibitor. |
|
V4601
|
Bamirastine |
215529-47-8 |
Bamirastine (also known as TAK-427),a new imidazopyridazine derivative, is a novelantihistamine compound withantiallergic effects. |